Literature DB >> 14991606

Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells.

Valérie Verhasselt1,2, Olivier Vosters1, Claire Beuneu1, Charles Nicaise1, Patrick Stordeur1, Michel Goldman1.   

Abstract

Current literature suggests that T cells recognizing antigen on mature dendritic cells (DC) differentiate into effector T cells whereas tolerance is induced when antigen is presented by immature DC. We investigated the consequences of the interactions between immature or lipopolysaccharide-matured DC and CD4(pos) T lymphocytes in absence of foreign antigen. While immature DC did not induce significant CD4(pos) T cell activation, we observed that a significant fraction of CD4(pos) T cells cultured with mature autologous DC displayed phenotypic features of activation and produced IL-2, IFN-gamma, IL-10 and TGF-beta. Furthermore, CD4(pos) T lymphocytes primed by mature, but not immature, autologous DC acquired regulatory properties. Indeed, when added to an allogeneic mixed leukocyte reaction, they suppressed the response of alloreactive T lymphocytes to the priming DC while responses to third-party stimulators were spared. The generation of CD4(pos) T cells with regulatory function by autologous stimulation did not require the presence of natural CD4(pos)CD25(pos) regulatory T cells. In addition, the acquisition of regulatory function by CD4(pos)CD25(neg) T cells stimulated by autologous mature DC was accompanied by the induction of FOXP3 expression. Our data suggest that during inflammatory conditions, presentation of self antigens by mature DC to autologous T lymphocytes could contribute to the generation of regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991606     DOI: 10.1002/eji.200324552

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  38 in total

1.  Curcumin induces maturation-arrested dendritic cells that expand regulatory T cells in vitro and in vivo.

Authors:  N M Rogers; S Kireta; P T H Coates
Journal:  Clin Exp Immunol       Date:  2010-12       Impact factor: 4.330

Review 2.  CD4+ Tregs and immune control.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

Review 3.  Recent advances in dendritic cell biology.

Authors:  Sylvia Adams; David W O'Neill; Nina Bhardwaj
Journal:  J Clin Immunol       Date:  2005-03       Impact factor: 8.317

Review 4.  CD4+ regulatory cells as a potential immunotherapy.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

5.  Large-scale depletion of CD25+ regulatory T cells from patient leukapheresis samples.

Authors:  Daniel J Powell; Linda L Parker; Steven A Rosenberg
Journal:  J Immunother       Date:  2005 Jul-Aug       Impact factor: 4.456

6.  FoxP3(+)CD4(+)CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn's disease.

Authors:  J Kelsen; J Agnholt; H J Hoffmann; J L Rømer; C L Hvas; J F Dahlerup
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

Review 7.  Recent advances in dendritic cell biology.

Authors:  Sylvia Adams; David W O'Neill; Nina Bhardwaj
Journal:  J Clin Immunol       Date:  2005-05       Impact factor: 8.317

Review 8.  Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.

Authors:  Jeffrey G Shannon; Robert A Heinzen
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

9.  Human CD4(+) effector T lymphocytes generated upon TCR engagement with self-peptides respond defectively to IL-7 in their transition to memory cells.

Authors:  Gabriela González-Pérez; Norma C Segovia; Amaranta Rivas-Carvalho; Diana P Reyes; Honorio Torres-Aguilar; Sergio R Aguilar-Ruiz; Claudine Irles; Gloria Soldevila; Carmen Sánchez-Torres
Journal:  Cell Mol Immunol       Date:  2013-03-04       Impact factor: 11.530

Review 10.  Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons.

Authors:  Diane E Griffin
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.